US

Amphivena Therapeutics lands $62 mln Series C

South San Francisco-based Amphivena Therapeutics Inc, a developer of T cell engager therapeutics for cancer, has raised $62 million in Series C financing. NanoDimension and Qiming Venture Partners USA led the round.

French medical device firm FeetMe snags Series A

Paris-based FeetMe, a medical device company, has raised 9.4 million euros in Series A funding. LBO France led the round with participation from Kurma Diagnostics, Paris Saclay seed fund, Idinvest Partners, Seventure and SOSV.

500 Startups recruits Wang as managing partner

San Francisco-based venture firm 500 Startups has named Tony Wang as a managing partner. Prior to joining 500 Startups, Wang was chief operating officer at Color.

Toronto AI SaaS startup ODAIA fetches $1.6 mln

Toronto-based ODAIA, an AI SaaS startup, has secured $1.6 million in funding. Panache Ventures and StandUp Ventures led the round with participation from BDC Capital’s Women in Technology Venture Fund, Inovia Capital and MaRS IAF. This new group of investors joins pre-seed investors that include Toronto Innovation Acceleration Partners, University of Toronto’s UTEST, N49P, Ontario Centres of Excellence and Amar Varma, co-founder of Autonomic.ai (acquired by Ford). The capital infusion will be used to make key technical hires, support early customers and prepare for the public launch of ODAIA’s AI SaaS platform.

Siguler Guff leads funding round for Chinese online marketplace Plum

Plum, a Chinese online marketplace for used fashion and luxury products, has secured $20 million in funding. Siguler Guff led the round with participation from Recruit.

Health tech company Lumasol nabs $3 mln seed

Lumasol, a health technology company, has secured $3 million in seed funding. The investors were Pathfinder at Founders Fund and Greycroft Ventures.

Residential rental startup Zumper hires new COO and president

San Francisco-based Zumper, a residential rental startup, has hired Vishal Makhijani as its new chief operating officer and president, according to a source at the firm. Makhijani is the former CEO of Udacity and ex-COO at Zynga. The investors included Axel Springer, Stereo Capital, Blackstone, Dawn Capital, Kleiner Perkins, Breyer Capital, Scott Cook and Goodwater Capital.

Panache Ventures raises C$58 mln for maiden fund

Panache Ventures, a seed-stage venture firm, has closed its debut fund at C$58 million, beating its initial $40 million target. The fund's investors include Alberta Enterprise Corporation, Fonds de solidarité FTQ, Investissement Québec, National Bank of Canada, TELUS Ventures, BMO Bank of Montreal and BC Tech Fund, managed by Kensington Capital. In March 2018, Panache announced it had raised C$25 million in the first close of the fund. Panache has offices in Montreal, Toronto, Calgary and Vancouver.

European CBD products maker KannaSwiss picks up $5.5 mln

KannaSwiss, a provider of European CBD products, has secured $5.5 million in funding. The investor was Altitude Investment Management plc.

VC-backed Aprea Therapeutics sets IPO pricing terms

Boston and Stockholm-based Aprea Therapeutics, a clinical-stage biotechnology company developing novel anticancer therapies targeting the p53 tumor suppressor protein, has priced its IPO of 5 million shares between $14 and $16 per share. Aprea is backed by Redmile Group, Rock Springs Capital, 5AM Ventures, Versant Ventures, HealthCap, Sectoral Asset Management and Karolinska Development AB.